![James J. Egan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James J. Egan
Plus aucun poste en cours
Historique de carrière de James J. Egan
Anciens postes connus de James J. Egan
Sociétés | Poste | Début | Fin |
---|---|---|---|
SUCAMPO PHARMACEUTICALS, INC. | Directeur des opérations | 15/09/2009 | 14/09/2012 |
ESBATech, a Novartis Co. GmbH
![]() ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Corporate Officer/Principal | 01/09/2009 | 01/09/2009 |
IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2006 | 01/01/2006 |
NeuronZ Ltd. | President | - | 01/06/2001 |
G.D. Searle & Co., Inc.
![]() G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | 01/06/2000 | 01/06/2000 |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/09/1993 | 01/09/1993 |
US Department of Justice | Corporate Officer/Principal | 01/01/1979 | - |
Tech Council of Maryland, Inc.
![]() Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 19/05/2010 | - |
Formation de James J. Egan
Georgetown University | Undergraduate Degree |
Santa Clara University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Suisse | 2 |
Nouvelle-Zélande | 2 |
Opérationnelle
Corporate Officer/Principal | 5 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Entreprise privées | 7 |
---|---|
Sucampo Pharmaceuticals, Inc.
![]() Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Tech Council of Maryland, Inc.
![]() Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
ESBATech, a Novartis Co. GmbH
![]() ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |
NeuronZ Ltd. | |
G.D. Searle & Co., Inc.
![]() G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
US Department of Justice | Government |
Idenix Pharmaceuticals LLC
![]() Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- James J. Egan
- Expérience